112 related articles for article (PubMed ID: 11290571)
1. Acquired hemophilia A associated with Epstein-Barr-virus-associated T/natural killer-cell lymphoproliferative disease: A case report.
Yamamoto M; Shindo M; Sumi C; Igarashi S; Saito T; Tsukada N; Toki Y; Hatayama M; Inamura J; Sato K; Mizukami Y; Torimoto Y; Okumura T
Medicine (Baltimore); 2021 Apr; 100(16):e25518. PubMed ID: 33879690
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-associated lymphoproliferative disorder developed after anti-thymocyte globulin therapy in a patient with bone marrow failure associated with T-cell large granular lymphocytic leukemia.
Sumi M; Watanabe M; Sato K; Shimizu I; Ueki T; Akahane D; Ueno M; Ichikawa N; Asano N; Kobayashi H
Rinsho Ketsueki; 2011 Nov; 52(11):1782-7. PubMed ID: 22185802
[TBL] [Abstract][Full Text] [Related]
3. Epstein Barr Virus-Related Acute Liver Failure and Hemophagocytosis in an Immunocompetent Individual: An Autopsy Report.
Mitra S; Hanumanthappa MK; Sarkar S; Bhalla A; Minz R; Ratho RK
Int J Surg Pathol; 2024 Jun; 32(4):838-844. PubMed ID: 37723947
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive polymerase chain reaction assay for detection of pathogenic DNA in lymphoproliferative disorders of the ocular adnexa.
Usui Y; Rao NA; Takase H; Tsubota K; Umazume K; Diaz-Aguilar D; Kezuka T; Mochizuki M; Goto H; Sugita S
Sci Rep; 2016 Nov; 6():36621. PubMed ID: 27830722
[TBL] [Abstract][Full Text] [Related]
5. A clinical analysis of hemophagocytic syndrome secondary to autoimmune diseases.
Liu Y; Li Q; Su Y; Che G; Liu Y; Qiao P; Liu S; Xu K
Arch Rheumatol; 2023 Sep; 38(3):406-418. PubMed ID: 38046247
[TBL] [Abstract][Full Text] [Related]
6. Hemophagocytic syndrome related by EBV infection: case report.
De Santis MC; Martinelli E; Cricchio AL; Mercatelli P; Campanaro G; D'Arienzo A; Pignone AM; Bandini G
Oxf Med Case Reports; 2024 May; 2024(5):omae045. PubMed ID: 38784782
[TBL] [Abstract][Full Text] [Related]
7. Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani.
Morimoto A; Omachi S; Osada Y; Chambers JK; Uchida K; Sanjoba C; Matsumoto Y; Goto Y
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004505. PubMed ID: 26942577
[TBL] [Abstract][Full Text] [Related]
8. Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.
Imadome K; Yajima M; Arai A; Nakazawa A; Kawano F; Ichikawa S; Shimizu N; Yamamoto N; Morio T; Ohga S; Nakamura H; Ito M; Miura O; Komano J; Fujiwara S
PLoS Pathog; 2011 Oct; 7(10):e1002326. PubMed ID: 22028658
[TBL] [Abstract][Full Text] [Related]
9. Emergence of anti-red blood cell antibodies triggers red cell phagocytosis by activated macrophages in a rabbit model of Epstein-Barr virus-associated hemophagocytic syndrome.
Hsieh WC; Chang Y; Hsu MC; Lan BS; Hsiao GC; Chuang HC; Su IJ
Am J Pathol; 2007 May; 170(5):1629-39. PubMed ID: 17456768
[TBL] [Abstract][Full Text] [Related]
10. Animal in vivo models of EBV-associated lymphoproliferative diseases: special references to rabbit models.
Hayashi K; Teramoto N; Akagi T
Histol Histopathol; 2002 Oct; 17(4):1293-310. PubMed ID: 12371154
[TBL] [Abstract][Full Text] [Related]
11. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
12. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management.
Su IJ; Wang CH; Cheng AL; Chen RL
Leuk Lymphoma; 1995 Nov; 19(5-6):401-6. PubMed ID: 8590839
[TBL] [Abstract][Full Text] [Related]
13. An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits.
Hayashi K; Ohara N; Teramoto N; Onoda S; Chen HL; Oka T; Kondo E; Yoshino T; Takahashi K; Yates J; Akagi T
Am J Pathol; 2001 Apr; 158(4):1533-42. PubMed ID: 11290571
[TBL] [Abstract][Full Text] [Related]
14. Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS.
Hayashi K; Jin Z; Onoda S; Joko H; Teramoto N; Ohara N; Oda W; Tanaka T; Liu YX; Koirala TR; Oka T; Kondo E; Yoshino T; Takahashi K; Akagi T
Am J Pathol; 2003 May; 162(5):1721-36. PubMed ID: 12707056
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic trials for a rabbit model of EBV-associated Hemophagocytic Syndrome (HPS): effects of vidarabine or CHOP, and development of Herpesvirus papio (HVP)-negative lymphomas surrounded by HVP-infected lymphoproliferative disease.
Hayashi K; Joko H; Koirala TR; Onoda S; Jin ZS; Munemasa M; Ohara N; Oda W; Tanaka T; Oka T; Kondo E; Yoshino T; Takahashi K; Yamada M; Akagi T
Histol Histopathol; 2003 Oct; 18(4):1155-68. PubMed ID: 12973684
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
